Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$68,750,423
+$43,634,322 QoQ
Shares Held
1,312,031
+84.7% QoQ
Ownership
0.782%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#29
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
This page
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,750,423 | 1,312,031 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $25,116,101 | 710,297 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,497,390 | 911,272 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,862,470 | 528,749 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $23,462,945 | 820,096 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,469,242 | 468,481 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,988,459 | 555,927 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,553,566 | 555,683 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,787,697 | 323,141 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,253,635 | 341,841 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,710,130 | 638,433 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $27,018,277 | 964,594 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,334,674 | 681,619 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,524,252 | 444,280 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,929,479 | 571,354 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,543,242 | 248,242 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,188,109 | 274,861 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,574,443 | 59,842 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,393,766 | 188,898 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,377,578 | 77,094 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,328,687 | 176,537 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,231,217 | 65,911 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,121,564 | 407,096 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $11,082,896 | 570,989 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,581,334 | 872,492 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||